EnerSys Announces Participation in CL King’s Best Ideas Conference on September 18, 2023
READING, Pa.–(BUSINESS WIRE)–#EnerSys—EnerSys (NYSE: ENS), the global leader in stored energy solutions for industrial applications,…
News
AeroVironment Announces Fiscal 2024 First Quarter Results
ARLINGTON, Va.–(BUSINESS WIRE)–$AVAV—AeroVironment, Inc. (“AeroVironment” or the “Company”) reported today financial results for the fiscal…
TD SYNNEX to Announce Third Quarter Fiscal 2023 Results on September 26, 2023
FREMONT, Calif. & CLEARWATER, Fla.–(BUSINESS WIRE)–TD SYNNEX (NYSE: SNX) today announced it will report its…
Public Storage Launches Savvy Insurance to Serve the Self-Storage Industry
GLENDALE, Calif.–(BUSINESS WIRE)–Public Storage (NYSE:PSA) announced today the launch of the Savvy Storage Insurance Program®…
Nucleome Therapeutics appoints Dr Russell Greig as Non-Executive Chair of the Board
Nucleome Therapeutics appoints Dr Russell Greig as Non–Executive Chair of the Board Dr Greig brings…
Nucleome Therapeutics appoints Dr Russell Greig as Non-Executive Chair of the Board
Nucleome Therapeutics appoints Dr Russell Greig as Non–Executive Chair of the Board Dr Greig brings…
VALNEVA Declaration of shares and voting rights: August 31, 2023
VALNEVA Declaration of shares and voting rightsAugust 31, 2023__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue…
Verona Pharma to Present Additional Analysis of Phase 3 ENHANCE-1 Study in COPD at ERS International Congress 2023
Substantial reductions in rate and risk of exacerbations support potential of ensifentrine, an investigational, novel,…
VALNEVA Declaration of shares and voting rights: August 31, 2023
VALNEVA Declaration of shares and voting rightsAugust 31, 2023__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue…
Verona Pharma to Present Additional Analysis of Phase 3 ENHANCE-1 Study in COPD at ERS International Congress 2023
Substantial reductions in rate and risk of exacerbations support potential of ensifentrine, an investigational, novel,…
Faron Pharmaceuticals Ltd. to Present at the H.C. Wainwright 25th Annual Global Investment Conference
TURKU, Finland and BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Faron Pharmaceuticals Ltd. (AIM: FARN, First…
Mendus Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference in September
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
Faron Pharmaceuticals Ltd. to Present at the H.C. Wainwright 25th Annual Global Investment Conference
TURKU, Finland and BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Faron Pharmaceuticals Ltd. (AIM: FARN, First…
Novartis appoints Patrick Horber, M.D., President, International as Marie-France Tschudin, President, Innovative Medicines International and Chief Commercial Officer, steps down from the Executive Committee of Novartis
After nearly seven years at Novartis and more than four years as a member of…
Mendus Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference in September
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
Novartis appoints Patrick Horber, M.D., President, International as Marie-France Tschudin, President, Innovative Medicines International and Chief Commercial Officer, steps down from the Executive Committee of Novartis
After nearly seven years at Novartis and more than four years as a member of…
Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference
Geneva, Switzerland, September 6, 2023 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical…
Idorsia reacquires the world-wide rights to aprocitentan
Ad hoc announcement pursuant to Art. 53 LR Aprocitentan, Idorsia’s oral, dual endothelin receptor antagonist…
Asana Announces Second Quarter Fiscal 2024 Results
Significant improvement towards profitability year over year Revenues from customers spending $5,000 or more grew…
OxyTap Launches OxyTap 5: Regenerative Oxygen Supplement Infuser at IFA Berlin 2023
OxyTap Pte Ltd launches OxyTap 5, a regenerative oxygen supplement infuser that increases oxygen levels…